scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1600-0676.2000.020003209.X |
P698 | PubMed publication ID | 10902970 |
P2093 | author name string | T Ohta | |
K Endo | |||
T Ueda | |||
T Terada | |||
P433 | issue | 3 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 209-215 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Liver | Q27711906 |
P1476 | title | Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma | |
P478 | volume | 20 |
Q36092123 | Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis |
Q37445665 | Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population |
Q40030453 | Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma |
Q33739952 | Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma |
Q30832108 | Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators |
Q35942016 | Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis |
Q24296626 | DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control |
Q24336795 | E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein |
Q34360157 | Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice |
Q35011207 | Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma |
Q46761401 | MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis |
Q39205410 | MDM2 is a useful prognostic biomarker for resectable gastric cancer |
Q52340395 | MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options? |
Q30165307 | Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma |
Q78357688 | Molecular pathogenesis of human hepatocellular carcinoma |
Q38280688 | Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis |
Q37225447 | Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway |
Q43137700 | RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. |
Q33825600 | Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo). |
Q37809251 | Signaling Networks in Human Hepatocarcinogenesis—Novel Aspects and Therapeutic Options |
Q40262791 | TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. |
Q46151710 | TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Search more.